+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Pain Management Drugs Market 2018-2022 - Product Image

Global Pain Management Drugs Market 2018-2022

  • ID: 4744623
  • Report
  • Region: Global
  • 117 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Endo Pharmaceuticals
  • GlaxoSmithKline
  • Johnson & Johnson
  • Pfizer
  • MORE
Numerous diseases and conditions are associated with pain, including arthritis, peripheral neurology, fibromyalgia and shingles. Low back pain is a common health problem in the workplace and most people are expected to experience symptoms of low back pain during their working life. Such an increase in the prevalence of chronic pain conditions will drive the global pain management drugs market during our forecast period. The analysts have predicted that the pain management drugs market will register a CAGR of nearly 4% by 2022.

Market Overview

Strong pipeline and recently approved pain management drugs

Most of the therapeutics that are in the last stage of development are expected to get marketing approval during our forecast period. Apart from the strong pipeline of late-stage molecules, recent approvals are expected to drive the global pain management drugs market.

High influx of generic drugs

Patent cliff and high prices of branded drugs result in a high influx of genetic drugs. The major reasons behind high drug prices are drug regulatory policies or industrial pricing strategies, and policy measures.

For the detailed list of factors that will drive and challenge the growth of the pain management drugs market during the 2018-2022, view this report.

Competitive Landscape

The pain management drugs market appears to be fragmented and with the presence of several companies including. The vendors in the market have strong R&D pipelines for new investigational pain management medicines. The robust pipelines for pain management drugs will likely propel the market’s growth. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.’
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Endo Pharmaceuticals
  • GlaxoSmithKline
  • Johnson & Johnson
  • Pfizer
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 05: PIPELINE ANALYSIS
  • Pain management pipeline
PART 06: MARKET SIZING
  • Market definition
  • Market sizing 2017
  • Market size and forecast 2017-2022
PART 07: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 08: MARKET SEGMENTATION BY PAIN TYPES
  • Segmentation by pain types
  • Nociceptive pain
  • Neuropathic pain
  • Psychogenic pain
PART 09: MARKET SEGMENTATION BY PRODUCT
  • Segmentation by product
  • Comparison by product
  • Opioids - Market size and forecast 2017-2022
  • NSAIDs - Market size and forecast 2017-2022
  • Others - Market size and forecast 2017-2022
  • Market opportunity by product
PART 10: CUSTOMER LANDSCAPE

PART 11: REGIONAL LANDSCAPE
  • Geographical segmentation
  • Regional comparison
  • Americas - Market size and forecast 2017-2022
  • EMEA - Market size and forecast 2017-2022
  • APAC - Market size and forecast 2017-2022
  • Market opportunity
PART 12: DECISION FRAMEWORK

PART 13: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 14: MARKET TRENDS
  • Increase in prevalence of pain associated with chronic diseases
  • Significant increase in the use of opioids for pain management
  • Novel drug delivery systems and novel targets for pain management
PART 15: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
PART 16: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Endo Pharmaceuticals
  • GlaxoSmithKline
  • Johnson & Johnson
  • Pfizer
PART 17: APPENDIX
  • List of abbreviations
List of Exhibits
Exhibit 01: Parent market
Exhibit 02: Global CNS therapeutics market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Pain management pipeline 2017-2018
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2017
Exhibit 08: Validation techniques employed for market sizing 2017
Exhibit 09: Global pain management drugs market - Market size and forecast 2017-2022 ($ mn)
Exhibit 10: Global pain management drugs market - Year-over-year growth 2018-2022 (%)
Exhibit 11: Five forces analysis 2017
Exhibit 12: Five forces analysis 2022
Exhibit 13: Bargaining power of buyers
Exhibit 14: Bargaining power of suppliers
Exhibit 15: Threat of new entrants
Exhibit 16: Threat of substitutes
Exhibit 17: Threat of rivalry
Exhibit 18: Market condition - Five forces 2017
Exhibit 19: Global pain management drugs market by product - Market share 2017-2022 (%)
Exhibit 20: Comparison by product
Exhibit 21: Opioids - Market size and forecast 2017-2022 ($ mn)
Exhibit 22: Opioids - Year-over-year growth 2018-2022 (%)
Exhibit 23: NSAIDs - Market size and forecast 2017-2022 ($ mn)
Exhibit 24: NSAIDs - Year-over-year growth 2018-2022 (%)
Exhibit 25: Others - Market size and forecast 2017-2022 ($ mn)
Exhibit 26: Selected current other types of drugs for neuropathic pain
Exhibit 27: Others - Year-over-year growth 2018-2022 (%)
Exhibit 28: Market opportunity by product
Exhibit 29: Customer landscape
Exhibit 30: Global pain management drugs market by geography - Market share 2017-2022 (%)
Exhibit 31: Regional comparison
Exhibit 32: Americas - Market size and forecast 2017-2022 ($ mn)
Exhibit 33: Americas - Year-over-year growth 2018-2022 (%)
Exhibit 34: Top 3 countries in Americas
Exhibit 35: EMEA - Market size and forecast 2017-2022 ($ mn)
Exhibit 36: EMEA - Year-over-year growth 2018-2022 (%)
Exhibit 37: Top 3 countries in EMEA
Exhibit 38: APAC - Market size and forecast 2017-2022 ($ mn)
Exhibit 39: APAC - Year-over-year growth 2018-2022 (%)
Exhibit 40: Top 3 countries in APAC
Exhibit 41: Market opportunity
Exhibit 42: Increasing geriatric population in Europe
Exhibit 43: Percentage of older Americans experiencing chronic pain conditions 2014
Exhibit 44: Some of the recently approved drugs by the US FDA for pain management
Exhibit 45: Some of the novel abuse-deterrent opioids and monoclonal antibodies
Exhibit 46: Vendor landscape
Exhibit 47: Landscape disruption
Exhibit 48: Vendors covered
Exhibit 49: Vendor classification
Exhibit 50: Market positioning of vendors
Exhibit 51: Endo Pharmaceuticals: An overview
Exhibit 52: Endo Pharmaceuticals - Business segments
Exhibit 53: Endo Pharmaceuticals - Organizational developments
Exhibit 54: Endo Pharmaceuticals - Segment focus
Exhibit 55: Endo Pharmaceuticals - Key offerings
Exhibit 56: GlaxoSmithKline: An overview
Exhibit 57: GlaxoSmithKline - Business segments
Exhibit 58: GlaxoSmithKline - Organizational developments
Exhibit 59: GlaxoSmithKline - Geographic focus
Exhibit 60: GlaxoSmithKline - Key offerings
Exhibit 61: Johnson & Johnson: An overview
Exhibit 62: Johnson & Johnson - Business segments
Exhibit 63: Johnson & Johnson - Organizational developments
Exhibit 64: Johnson & Johnson - Geographic focus
Exhibit 65: Johnson & Johnson - Segment focus
Exhibit 66: Johnson & Johnson - Key offerings
Exhibit 67: Pfizer: An overview
Exhibit 68: Pfizer - Business segments
Exhibit 69: Pfizer - Organizational developments
Exhibit 70: Pfizer - Geographic focus
Exhibit 71: Pfizer - Segment focus
Exhibit 72: Pfizer - Key offerings
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Endo Pharmaceuticals
  • GlaxoSmithKline
  • Johnson & Johnson
  • Pfizer
  • MORE
Global Pain Management Drugs Market 2018-2022

The analyst recognizes the following companies as the key players in the global pain management drugs market: Endo Pharmaceuticals, GlaxoSmithKline, Johnson & Johnson, Pfizer.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the novel drug delivery systems and novel targets for pain management.”

According to the report, one of the major drivers for this market is the strong pipeline and recent approvals are expected to drive the global pain management drugs market.

Further, the report states that one of the major factors hindering the growth of this market is many payers and government- funded reimbursement schemes are applicable for a few acute pains and chronic pain conditions. This pose a challenge for the global pain management drugs market.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • Endo Pharmaceuticals
  • GlaxoSmithKline
  • Johnson & Johnson
  • Pfizer
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4744623
Adroll
adroll